Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 42 min ago
Peer-reviewedCC BYFrontiers in oncology

FOXM1 as a candidate dosage rheostat and state selector in breast cancer: linking multilevel regulation to adaptive plasticity and therapy resistance

  • Ghaleb Oriquat1
  • Hani Moslem Ahmed2
  • Jasur Rizaev3
  • Mamura Kucharova4
  • Djamila Polatova5
  • Mrtda Adnan Mhysn6
  • Navin Kumar Tailor7
7 affiliations
  1. 1Faculty of Allied Medical Sciences, Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University , ,
  2. 2College of Pharmacy, Alnoor University , ,
  3. 3Department of Public health and Healthcare management, Rector, Samarkand State Medical University , ,
  4. 4Department of Morphological Sciences, Termez University of Economics and Service , ,
  5. 5Scientific-Practical Medical Center for Pediatric Oncology, Hematology and Immunology , ,
  6. 6Department of Pharmacy, College of Pharmacy, The Islamic University , ,
  7. 7University Institute of Pharma Sciences, Chandigarh University , , ,
Read full textPDFCite

Related

  1. Mechanism-Matched Pharmacology of Resistance in EGFR-Mutant NSCLC: Genomic Bypass, Lineage Plasticity, Antibody-Drug Conjugates, and Candidate Biophysical Targets
    Yohan Seo
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0General medicineCrossref
  2. Aging concomitantly reduces skeletal muscle proteome plasticity and hypertrophic responses to resistance training in male adults
    Dustyn T. Lewis, J. Max Michel, Mason C. McIntosh +14
    Physiological reportsPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Epigenetic regulation of cancer stem cell plasticity and relapse competence in EGFR-mutant lung cancer
    Xiangxiang Sun, Shengshan Xu, Qian Guo
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMCEurope PMC
  4. Epigenetic and metabolic plasticity of tumor cells in immunotherapy resistance
    Jee-Eun Choi, Inwha Baek
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  5. MSC C1: A Potential Hub Linking Stromal Plasticity, Immune Regulation, and Patient Survival in Lung Adenocarcinoma.
    Houlei Wang, Tianle Ma, Chao Jia +1
    Chemical biology & drug designPeer-reviewedCC BYFull textOncologyEurope PMC

Cite

BibTeXRIS
BibTeX
@article{oriquat2026foxm1,
  title = {{FOXM1 as a candidate dosage rheostat and state selector in breast cancer: linking multilevel regulation to adaptive plasticity and therapy resistance}},
  author = {Ghaleb Oriquat and Hani Moslem Ahmed and Jasur Rizaev and Mamura Kucharova and Djamila Polatova and Mrtda Adnan Mhysn and Navin Kumar Tailor},
  journal = {Frontiers in oncology},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13656084},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - FOXM1 as a candidate dosage rheostat and state selector in breast cancer: linking multilevel regulation to adaptive plasticity and therapy resistance
AU  - Ghaleb Oriquat
AU  - Hani Moslem Ahmed
AU  - Jasur Rizaev
AU  - Mamura Kucharova
AU  - Djamila Polatova
AU  - Mrtda Adnan Mhysn
AU  - Navin Kumar Tailor
PY  - 2026
DA  - 2026/10/16
JO  - Frontiers in oncology
UR  - https://europepmc.org/article/PMC/PMC13656084
SN  - 2234-943X
ER  -